In this video, Naeem Bhojani, MD, FRCSC, and David-Dan Nguyen discuss the patient selection, learning curve and takeaways of the study, “WATER vs WATER II: Three Year Comparison of Aquablation Therapy for Benign Prostatic Hyperplasia,” presented at the 2021 American Urological Association Annual Meeting. Bhojani is a urologist at CHUM Research Centre and an associate professor in the departments of surgery and social and preventative medicine at the University of Montreal, and Nguyen is a medical student at McGill University, Montreal, Quebec, Canada.
Academic, private practice urologists collaborate to change BPH reimbursement
April 1st 2024"We really aimed to affect 3 different contraindications and instead achieved retirement of the entire policy, which, we think, really opens up this wonderful technology to literally hundreds of thousands more patients across the country," says Arpeet Shah, MD.